These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37197618)

  • 1. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
    Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H
    Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas.
    Hsieh MS; Kao HL; Huang WC; Wang SY; Lin SY; Chu PY; Pan CC; Chou TY; Ho HL; Yeh YC
    Mod Pathol; 2023 Feb; 36(2):100008. PubMed ID: 36853782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.
    Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J
    Front Oncol; 2021; 11():667148. PubMed ID: 34307137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
    Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
    Front Oncol; 2021; 11():647512. PubMed ID: 34568003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique correlation between GTF2I mutation and spindle cell morphology in thymomas (type A and AB thymomas).
    Wells K; Lamrca A; Papaxoinis G; Wallace A; Quinn AM; Summers Y; Nonaka D
    J Clin Pathol; 2023 Jul; 76(7):463-466. PubMed ID: 35039450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
    Elm L; Levidou G
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
    He Y; Kim IK; Bian J; Polyzos A; Di Giammartino DC; Zhang YW; Luo J; Hernandez MO; Kedei N; Cam M; Borczuk AC; Lee T; Han Y; Conner EA; Wong M; Tillo DC; Umemura S; Chen V; Ruan L; White JB; Miranda IC; Awasthi PP; Altorki NK; Divakar P; Elemento O; Apostolou E; Giaccone G
    J Thorac Oncol; 2022 Dec; 17(12):1375-1386. PubMed ID: 36049655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations in thymoma-molecular pathogenesis?
    Oberndorfer F; Müllauer L
    J Thorac Dis; 2020 Dec; 12(12):7536-7544. PubMed ID: 33447444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
    Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
    Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
    Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
    Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis.
    Kostic Peric J; Cirkovic A; Srzentic Drazilov S; Samardzic N; Skodric Trifunovic V; Jovanovic D; Pavlovic S
    Radiol Oncol; 2023 Mar; 57(1):12-19. PubMed ID: 36942904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets.
    Alwahsh M; Knitsch R; Marchan R; Lambert J; Hoerner C; Zhang X; Schalke B; Lee DH; Bulut E; Graeter T; Ott G; Kurz KS; Preissler G; Schölch S; Farhat J; Yao Z; Sticht C; Ströbel P; Hergenröder R; Marx A; Belharazem D
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
    Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
    Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic Epithelial Tumors: An Evolving Field.
    Kuhn E; Pescia C; Mendogni P; Nosotti M; Ferrero S
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations of thymic epithelial tumors with myasthenia gravis.
    Pardini E; Cucchiara F; Palumbo S; Tarrini G; Di Vita A; Coppedè F; Nicolì V; Guida M; Maestri M; Ricciardi R; Aprile V; Ambrogi MC; Barachini S; Lucchi M; Petrini I
    Front Oncol; 2023; 13():1224491. PubMed ID: 37671056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
    Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
    BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
    Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
    Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.
    Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M
    Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.